Histiocytoid Sweet syndrome
Authors: Kirsty JL Wark and Helena Crawshaw
Published online: 4 November 2019

A 48‐year‐old man presented with a 3‐day history of a rapidly progressing painful and pruritic cutaneous eruption and fever. He had used methamphetamine a week before the eruption. His past medical history was otherwise unremarkable. The eruption was photodistributed, with erythematous to violaceous papules and pseudo‐bullae in the face, ears, neck, upper chest and the dorsal aspect of his forearms and hands (Figure, A and B). He was febrile and tachycardic. Full blood count revealed a neutrophilia. An infective screen was negative. Biopsies demonstrated subepidermal oedema and a dense dermal infiltrate composed of neutrophils, histiocytes and lymphocytes, consistent with histiocytoid Sweet syndrome. Solid organ and haematological malignancy screening were negative. He was treated with prednisolone 30 mg daily and topical emollient therapies, with resolution of his fevers and cutaneous eruption within 10 days. Histiocytoid Sweet syndrome can be idiopathic, associated with underlying malignancy, or drug‐induced.1,2
Competing interests
Acknowledgements
References
- Requena L, Kutzner H, Palmedo G, et al. Histiocytoid Sweet syndrome: a dermal infiltration of immature neutrophilic granulocytes. Arch Dermatol 2005; 141: 834–842.
- Wu AJ, Rodgers T, Fullen DR. Drug‐associated histiocytoid Sweet's syndrome: a true neutrophilic maturation arrest variant. J CutanPathol 2008; 35: 220–224.
Hospital-Admitted Injection-Related Infections Among Incarcerated People Who Inject Drugs in Australia: A Retrospective Cohort Study
Andrew Palmer, Matthew Carter, Jeremy Yeo, Cecilia Shim, Jason Connor, Jeremy Hayllar, Gerald Holtmann, Naomi Moy, Elliott G. Playford, Naomi Runnegar, Paul J. Clark
The Live Attenuated Influenza Vaccine in Australia: An Additional Tool for Influenza Prevention
Cyra Patel, Alexis Pillsbury, Tran Nguyen, Xia Wang, Helen E. Quinn, Clayton K. Chiu, Allen C. Cheng, Katie L. Flanagan, Zhicheng Wang
Reflex Testing for Hepatitis D Infection: A Unique Opportunity to Reduce Hepatitis D-Related Chronic Liver Disease Deaths in Australia
Jessica Howell, Lauren Andersson, Miriam T. Levy, James O'Beirne, Leon Adams, Katharine Irvine, Avik Majumdar, Golo Ahlenstiel, Kathy Jackson, Krispin Hajkowicz, Joseph Doyle, Jane Davies, Sarah Cherian, Wayne Dimech, Alexander J. Thompson
Localised Herpes Simplex Following Midline Laparotomy
Jessica S. Bulluss, Paul Chee, Matthew J. Verheyden
West Nile virus Kunjin subtype in rural NSW
Emily Gibson, Megan Whitley, Peter Murray, Linda Hueston, Jane Bennett, Raguharan Kathiresu, David N Durrheim
Differentiated and simplified oral HIV pre‐exposure prophylaxis (PrEP) models hold the key to virtually eliminating HIV transmission in Australia by 2030
Tyson Arapali, Sarah Warzywoda, Anthony K J Smith, Curtis Chan, Timothy R Broady, Erin Sullivan, Catherine MacPhail, Mohamed A Hammoud, Alexander Dowell‐Day, Benjamin R Bavinton